FAP and neoplasm: Second, they suggest that selectively targeting these pathways at their stromal source—using antibodies, small-molecule inhibitors, or fibroblast activation protein (FAP)-guided nanosystems—can normalize CAF function and remodel the tumor microenvironment (TME).